(주)알티큐어

{
  "address": "대전광역시 유성구",
  "ceo_name": "김연수",
  "certificate": [
    {
      "cert_number": "20190100098",
      "changes": "",
      "disclosure_date": "2019-01-04",
      "first_cert_date": "2019-01-04",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2019-01-04 ~ 2021-01-03"
    },
    {
      "cert_number": "20200116481",
      "changes": "",
      "disclosure_date": "2020-12-22",
      "first_cert_date": "2019-01-04",
      "no": "2",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2021-01-04 ~ 2023-01-03"
    },
    {
      "cert_number": "20230125030119",
      "changes": "",
      "disclosure_date": "2023-01-25",
      "first_cert_date": "2019-01-04",
      "no": "3",
      "type": "혁신성장유형",
      "valid_period": "2023-01-04 ~ 2026-01-03"
    },
    {
      "cert_number": "20251231030047",
      "changes": "",
      "disclosure_date": "2025-12-31",
      "first_cert_date": "2019-01-04",
      "no": "4",
      "type": "혁신성장유형",
      "valid_period": "2026-01-04 ~ 2029-01-03"
    }
  ],
  "company_name": "(주)알티큐어",
  "corp_no": "160111-*******",
  "financials": {
    "2022": {
      "capital_stock": 200000000,
      "cost_of_sales": 0,
      "current_assets": 1361407000,
      "current_liabilities": 66588000,
      "gross_profit": 1509187000,
      "net_income": 680778000,
      "net_income_bs": 680778000,
      "non_current_assets": 133416000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 2351000,
      "non_operating_income": 983000,
      "operating_profit": 682146000,
      "revenue": 1509187000,
      "sga_expenses": 827041000,
      "total_assets": 1494823000,
      "total_equity": 1428235000,
      "total_liabilities": 66588000
    },
    "2023": {
      "capital_stock": 200000000,
      "cost_of_sales": 0,
      "current_assets": 1274504000,
      "current_liabilities": 16988000,
      "gross_profit": 1014970000,
      "net_income": -7576000,
      "net_income_bs": -66365000,
      "non_current_assets": 97607000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 1739000,
      "non_operating_income": 37057000,
      "operating_profit": -42894000,
      "revenue": 1014970000,
      "sga_expenses": 1057864000,
      "total_assets": 1372111000,
      "total_equity": 1355123000,
      "total_liabilities": 16988000
    },
    "2024": {
      "capital_stock": 200000000,
      "cost_of_sales": 0,
      "current_assets": 437697000,
      "current_liabilities": 18767000,
      "gross_profit": 723127000,
      "net_income": -310287000,
      "net_income_bs": -310287000,
      "non_current_assets": 629377000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 7508000,
      "non_operating_income": 45045000,
      "operating_profit": -347824000,
      "revenue": 723127000,
      "sga_expenses": 1070951000,
      "total_assets": 1067074000,
      "total_equity": 1048307000,
      "total_liabilities": 18767000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [],
  "main_products": "유전자 치료제 및 관련 원천 기술",
  "phone": "042-821-****",
  "years": [
    2024,
    2023,
    2022
  ]
}